semaglutide compound deaths Patient Safety Updates FDA Warns on Certain Forms

Ipamorelin Nasal Spray Benefits Non-Invasive Application: The nasal spray method offers a practical and user-friendly alternative to subcutaneous injections, enhancing participant adherence and comfort during studies on growth hormone dynamics

Commenting over Lupin upcoming launches in the US, the CEO stated, that the target launch date for Rituximaba therapy for blood canceris set for June 2026." Meanwhile, at the call, Ramesh Swaminathan, Global CFO, Lupin, informed that the company expects its diagnostics business to achieve breakeven EBITDA by the end of this year (2025)

Interaction between specific fatty acids, GLP-1 and insulin secretion in humans

for Saxenda, evaluate at 16 weeks with a target of 4% weight loss